Latest news
Amgen Reports Strong Q2 Drug Sales, Raises Guidance, and Will End Early-Stage Weight-Loss Drug Development - BitgetBitget · Wed, 05 Aug 2026 00:23:49 GMTAmgen drops ph. 1 obesity drug, upping pressure on MariTide - Fierce BiotechFierce Biotech · Tue, 04 Aug 2026 20:23:55 GMTAmgen Raises 2026 Sales Forecast After Strong Q2 Beat - Briefs FinanceBriefs Finance · Tue, 04 Aug 2026 20:07:57 GMTAmgen Weight Loss Drug: MariTide Review – Is Monthly Dosing the Edge Over Weekly Options? *XTayL406T* - Diario ASDiario AS · Mon, 03 Aug 2026 13:16:14 GMTWatch Out, Eli Lilly and Novo Nordisk: Amgen's Monthly Weight Loss Drug Has 6 Phase 3 Trials Running -- and It's Coming for Your Patients - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMTAmgen's MariTide Aims to Disrupt Obesity Drug Market - Intellectia AIIntellectia AI · Wed, 29 Jul 2026 07:00:00 GMT